Investor Presentation_ Japan Summer School_ Medical Technology

Summary of Key Points from the Conference Call Industry Overview - Industry: Medical Technology in Japan - Research Firm: Morgan Stanley MUFG Securities Co., Ltd. - Analysts: Ryotaro Hayashi, Erina Tokunaga - Industry View: In-Line [1][4] Companies Discussed 1. Terumo (4543) - Sales: Y1.04 trillion for F3/25, with segments including Cardiac & Vascular, Medical Care Solutions, and Blood & Cell Technologies [8] - Key Topics: Official reimbursement prices for medical devices have seen significant reductions, with average price changes ranging from -1% to -15% across various products [19] 2. Olympus (7733) - Sales: Y997.3 billion for F3/25, with segments including Endoscopic Solutions and Therapeutic Solutions [25] - Key Innovations: Introduction of new endoscopy series "EVIS X1" and a cloud-based digital endoscopy suite "OLYSENSE" [42] 3. Sysmex (6869) - Sales Breakdown: Hematology (Y303.2 billion, 60% of sales), with a market share of 54% [43][44] - Recent Developments: Launch of an In Vitro test for Alzheimer's disease [45] 4. M3 (2413) - Sales: Y284.9 billion for F3/25, focusing on medical platforms and evidence solutions [52] - Key Topic: Development of AI-powered, cloud-based EHR systems to enhance medical care efficiency [56] 5. Asahi Intecc (7747) - Sales: Y107.5 billion for F6/24, with a focus on medical components and OEM [60] - Market Share: Dominates PTCA guidewire market in Japan [63] 6. Nihon Kohden (6849) - Sales: Breakdown includes patient monitors and physiological measuring equipment [71] 7. JMDC (4483) - Sales: Y41.7 billion for F3/25, focusing on healthcare big data and telemedicine [76] 8. Nipro (8086) - Sales: Y644.6 billion for F3/25, with a significant portion from dialysis-related products [79] - Market Share: Holds 36% of the global market for dialyzers [82] 9. H.U. Group Holdings (4544) - Sales: Y243.0 billion for F3/25, focusing on In Vitro Diagnostics [86] 10. PHC Holdings (6523) - Sales: Y361.6 billion for F3/25, with segments in diabetes management and diagnostics [100] 11. Hogy Medical (3593) - Key Topic: Sales by product categories, including premium kits and conventional products [115] 12. Tauns Laboratories (197A) - Market Share: Significant presence in domestic antigen tests for infectious diseases [123] 13. EUCALIA (286A) - Sales: Y19.8 billion for 2024, focusing on medical management support [128] Important Trends and Insights - Price Reductions: Many medical devices are experiencing price reductions, impacting revenue and margins across the industry [19] - Innovation: Companies are focusing on technological advancements, such as AI in healthcare and new medical devices, to maintain competitive advantages [42][56] - Market Dynamics: The medical technology sector in Japan is characterized by strong competition and significant market shares held by leading companies [44][63][82] Conclusion The medical technology industry in Japan is evolving with significant sales figures reported by major companies. Innovations and price adjustments are key themes, indicating a dynamic market landscape.